STADA and Alvotech launch Uzpruvo, the first approved ustekinumab biosimilar to Stelara, across Europe Launch of European-made Uzpruvo in Europe comes immediately upon expiry of exclusivity rights for the molecule used to treat certain conditions...
► Artikel lesen

TORONTO, ON / ACCESSWIRE / July 15, 2024 / Amaroq Minerals Ltd. ("Amaroq," "Company" or the "Corporation")(AIM:AMRQ)(TSXV:AMRQ)(NASDAQ:AMRQ)(Iceland:AMRQ), an independent mine development company with a substantial land package of gold and strategic...
► Artikel lesen

Revenues of EUR 415m and EBIT improving to 9.1%, revised outlook for 2024 on the back of soft orders received Executive summaryEBIT margin of 9.1% in 2Q24, improving both QoQ and YoY.Soft orders received with book-to-bill ratio of 0.95 and order book...
► Artikel lesen

EBIT USD 3.3 million and net profit USD 0.6 million on a capacity increase of 8%Positive cost development reflected in a 2.4% decrease in unit cost despite high inflationFleet renewal, cost control, and increased operational efficiency contributed...
► Artikel lesen

Íslandsbanki reported a net profit of ISK 5.3 billion in the second quarter of 2024 and ISK 10.7 billion for the first half of 2024. Second quarter (2Q24) financial highlightsÍslandsbanki reported a net profit of ISK 5.3 billion in the second quarter...
► Artikel lesen